STOCK TITAN
  1. Home
  2. News
  3. MLSS

Milestone Scientific Inc. - MLSS STOCK NEWS

Welcome to our dedicated news page for Milestone Scientific (Ticker: MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scientific.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Milestone Scientific's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Milestone Scientific's position in the market.

News
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
Rhea-AI Summary
Milestone Scientific Inc. (MLSS) announces the commencement of sales of CompuFlo® Epidural disposables into PRC Alliance Pain Relief Center in Florida. Dr. Bakshi reports 100% success in Epidural Steroid Injection procedures, praising the system for enhancing speed and safety. Milestone Scientific aims to advance sales of their technology in pain clinics nationwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
none
-
News
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
Rhea-AI Summary
Milestone Scientific Inc. reports a successful year in 2023 with revenue up by 11.6% and gross profit increasing by 39%. The company attributes this growth to the success of its new online sales portal for the STA Single Tooth Anesthesia System® in the U.S. The CEO, Arjan Haverhals, highlights the termination of the prior exclusive distributor in 2022 and the successful transition to a direct sales model. The company is also focusing on international expansion in 2024. Milestone Scientific is advancing the rollout of the CompuFlo® Epidural System, with progress in penetrating key hospitals and pain management clinics. The company is working on accelerating reimbursement claims submission and has seen a significant increase in claims activity. Financially, the company ended 2023 with approximately $6.0 million in cash, cash equivalents, and marketable securities, showing confidence in executing its growth strategy without additional funds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.33%
Tags
none
-
News
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
Rhea-AI Summary
Milestone Scientific Inc. (MLSS) will host a conference call to discuss its financial results for 2023 and corporate progress on April 1, 2024. The call will be available via telephone and webcast, with an audio replay option until April 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
earnings
News
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) announces the commencement of sales of CompuFlo® Epidural disposables to Omaha Pain Physicians, following a successful evaluation by Dr. Matthew Stottle, reporting 100% success rate in 10 cases. The technology offers safety enhancements for Epidural Steroid Injection procedures, reinforcing the ongoing success and safety of the CompuFlo system.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.14%
Tags
none
-
News
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio
Rhea-AI Summary
Milestone Scientific Inc. (MLSS) announces the commencement of direct sales of its STA Single Tooth Anesthesia System® with Meridian Endo & Perio, a dental practice in Wisconsin. The system is praised for its ease of use and patient comfort, leading to expanded adoption within the practice. The CEO highlights the benefits of the new direct sales model and anticipates steady revenue growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.59%
Tags
none
-
News
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast
Rhea-AI Summary
Milestone Scientific Inc. (MLSS) announces the commencement of sales of its STA Single Tooth Anesthesia System® with Maine Dental Group. The agreement reflects the success of their new sales strategy targeting Dental Service Organizations (DSOs) and large group practices. The partnership aims to enhance patient experience, improve practice efficiency, and drive greater awareness of Milestone's technology in the dental industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update
Rhea-AI Summary
Milestone Scientific Inc. (MLSS) reports initial reimbursements of CompuFlo® by commercial payors and Medicare. The CEO, Arjan Haverhals, updates shareholders on the successful commercialization of the CompuFlo technology and the positive traction it has gained. The company has received FDA clearance for expanded use of the technology and has launched a reimbursement plan to support pain management providers. The advisory sites implementing CompuFlo technology have reported a 100% success rate for patient procedures, with zero dural punctures. The University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital has expanded the use of CompuFlo beyond the labor and delivery department, demonstrating the positive clinical feedback received. The company is focused on increasing the number of CompuFlo providers in the US and accelerating patient access to the technology through ongoing education and engagement with payors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none
-
News
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) closed a public offering of 4,765,000 shares of common stock at $0.63 per share, generating approximately $3.0 million in gross proceeds. The underwriter has a 45-day option to purchase up to an additional 714,750 shares. The Offering was disclosed in a final prospectus supplement on December 12, 2023, following the registration statement's effectiveness on October 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
offering
-
News
Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) has announced the pricing of an underwritten public offering of 4,765,000 shares of its common stock at a price of $0.63 per share, expected to generate approximately $3.0 million in gross proceeds. The Offering is expected to close on December 13, 2023, with Maxim Group LLC acting as the sole book-runner. The Company has also granted the underwriter a 45-day option to purchase up to an additional 714,750 shares of common stock on the same terms and conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.68%
Tags
offering
News
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock
Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) has commenced an underwritten public offering of shares of its common stock, with an option to purchase additional shares. Maxim Group LLC is acting as the sole book-runner for the Offering. The Offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-275088) previously filed with the U.S. Securities and Exchange Commission ('SEC').
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
offering
Stock MLSS logo
Milestone Scientific Inc.

NYSE:MLSS

MLSS Rankings

#4788 Ranked by Market Cap
#804 Ranked by Stock Gains
N/A Ranked by Dividends

MLSS Stock Data

46.63M
50.52M
14.41%
5.7%
0.52%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Roseland

About MLSS

milestone scientific has developed and currently manufactures, markets and sells “computer-controlled local anesthetic delivery” (c-clad) systems for the improved and painless delivery of local anesthetic. the system is marketed in dentistry under the trademarks compudent & sta system (newest technology). sta™ system is suitable for all dental procedures. compudent™ and the more advanced sta™ system are suitable for all dental injections regularly used in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics and a number of other disciplines. compudent and the sta system is sold in the united states and worldwide in over 25 countries.